Medline Inc. (mdln)
MDLN — Company Overview
Medline Inc. (MDLN) trades on NMS as part of the Healthcare peer group (Medical Instruments & Supplies).
| Ticker | MDLN |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Exchange | NMS |
| Market cap | $46.15B |
| Last price | $34.30 |
| Size category | Large Cap |
MDLN — Business Description
MDLN represents a Medical Instruments & Supplies business in the Healthcare segment. Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and…
Official website: https://www.medline.com.
MDLN — Investment Thesis
At a high level, MDLN offers exposure to Healthcare with metrics outlined below from public market data.
- Revenue is expanding at roughly 11.6% year-over-year (public data).
- Trailing P/E of 42.88× implies elevated growth expectations at the current price.
- Forward P/E (21.70×) is below trailing P/E — earnings may be expected to improve.
- Equity market capitalization is approximately $46.15B.
See the free estimates and earnings pages for public targets and growth metrics. Ownership, live news, and deeper models remain in Vest Terminal.
MDLN — Financial Health
Key financial health indicators for Medline Inc. are derived exclusively from public data — no proprietary estimates.
Profit margin near 2.3% leaves a narrower cushion versus higher-margin peers. Positive free cash flow of $850.63M supports balance-sheet flexibility.
| Trailing P/E | 42.88× |
| Forward P/E | 21.70× |
| Price / Sales | 1.54× |
| Price / Book | 2.60× |
| Gross margin | 25.1% |
| Operating margin | 0.8% |
| Profit margin | 2.3% |
| Return on equity | 4.9% |
| Debt / Equity | 66.26 |
| Free cash flow | $850.63M |
MDLN — Growth Outlook
Growth outlook for Medline Inc. (MDLN) depends on demand trends in Medical Instruments & Supplies and the company's ability to convert revenue into sustainable earnings.
- Revenue growth of 11.6% indicates strong top-line momentum.
- Earnings growth of 2.6% year-over-year supports improving profitability.
- Price is 32.6% below the 52-week high.
- Shares trade 8.9% above the 52-week low — limited rebound so far.
MDLN — Competitive Position
Medline Inc. (MDLN) is evaluated against peers on scale, margin structure, and capital efficiency within Healthcare.
- Competes within Healthcare, specifically in Medical Instruments & Supplies.
- Market capitalization of $46.15B places MDLN among large-cap peers.
- Gross margin of 25.1% should be benchmarked against direct competitors.
MDLN — Strengths
Strengths for Medline Inc. (MDLN) inferred from public financial metrics:
- Revenue growth of 11.6% year-over-year.
- Earnings growth of 2.6% year-over-year.
- Positive free cash flow ($850.63M).
- Moderate leverage (debt/equity 66.26).
- Large Cap scale ($46.15B) may provide distribution and funding advantages.
MDLN — Weaknesses
Weaknesses and pressure points for Medline Inc. (MDLN) based on available data:
- Elevated trailing P/E (42.88×) limits valuation margin of safety.
- Thin profit margin (2.3%).
- Price 33% below the 52-week high — sustained negative sentiment.
MDLN — Opportunities
- Sustained revenue growth (11.6%) could support multiple expansion if margins hold.
- Trading 8.9% above the 52-week low — potential recovery if fundamentals stabilize.
- Positive free cash flow enables reinvestment, debt reduction, or shareholder returns.
- Forward earnings multiple below trailing P/E — potential earnings acceleration ahead.
MDLN — Risks
- Rich valuation (P/E 42.88×) increases downside if growth slows.
- Thin margins leave less room for operational missteps.
MDLN — Summary
Medline Inc. (MDLN) is a large-cap Healthcare company focused on Medical Instruments & Supplies, listed on NMS. Last price $34.30 with market cap $46.15B. Trailing P/E 42.88×. Revenue grew 11.6% year-over-year per public data. Notable strengths include revenue growth of 11.6% year-over-year. Key watch items include elevated trailing p/e (42.88×) limits valuation margin of safety. Premium Terminal tools for Medline Inc. add ownership analytics, news, and richer estimate history beyond this public summary.
Start Free — open MDLN in Vest Terminal
Access live data, filings, ownership, and analysis for Medline Inc..
Medline Inc. FAQ
What does Medline Inc. (MDLN) do?
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The M…
What is MDLN's P/E ratio?
Medline Inc. has a trailing P/E of 42.88× based on publicly available market data.
Does MDLN pay a dividend?
Indicated dividend yield: none reported. Confirm ex-dates and payout history in Vest Terminal.
What sector is MDLN in?
Medline Inc. is classified in Healthcare (Medical Instruments & Supplies) on NMS.
What is MDLN's market capitalization?
Approximate market cap: $46.15B.
What are the main risks for MDLN?
Key risks include elevated valuation, among factors on this page.
What are the strengths of MDLN?
Potential positives include revenue growth of 11.6% year-over-year, earnings growth of 2.6% year-over-year.
Where can I get analyst estimates for MDLN?
Public analyst price targets and consensus for Medline Inc. are on the free /stocks/mdln/estimates page. Deeper estimate history and models are available in Vest Terminal.